跳至主要内容
临床试验/NCT01141400
NCT01141400已完成不适用

The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy Use

Otsuka Pharmaceutical Development & Commercialization, Inc.0 个研究点目标入组 48,865 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
48,865
主要终点
The primary outcome is any use of adjunctive treatment (combined and by class) and the time to initiation of adjunctive treatment (combined and by class).

研究概览

简要总结

The primary objective of this study is to measure the effects of patient cost-sharing on the initiation of adjunctive treatment and subsequent healthcare utilization and expenditures among a population of commercially insured adults on antidepressant therapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (aged 18-64) will be selected from the MarketScan Commercial Database between January 1, 2004, and September 30, 2008, if they have at least two medical claims with a diagnosis of depression and at least one prescription fill for an antidepressant medication.

排除标准

  • Patients who have any claim with a diagnosis of dementia, schizophrenia, delusional disorder, psychoses, pervasive development disorder, mental retardation, cerebral degenerations, Parkinson's disease, senility, manic depression, bipolar disorder, or major depressive disorder with psychotic symptoms.

结局指标

主要结局

The primary outcome is any use of adjunctive treatment (combined and by class) and the time to initiation of adjunctive treatment (combined and by class).

时间窗: 16 months

16 months of medical and prescription drug coverage after the initial antidepressant prescription claim

次要结局

  • sensitivity to cost-sharing will be examined as a function of treatment resistance(16 months)

研究者

相似试验